PHATHOM PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.42 USD | +3.17% |
|
+5.33% | +12.60% |
| 02:06pm | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 03 | Stifel Starts Phathom Pharmaceuticals With Buy Rating, $24 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | +1.78% | +5.33% | +12.60% | -14.26% | - | 591M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PHAT Stock
- Charts Phathom Pharmaceuticals, Inc.
- Comparison Chart